Pharmaids Pharmaceuticals
51.90
+1.95(+3.90%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+3.90%
1M+7.65%
6M-10.32%
1Y-18.77%
5Y+233.98%
View Company Insightsright
More news about Pharmaids Pharmaceuticals
07Aug 25
Open Offer for Pharmaids Pharmaceuticals at ₹62.15 per Share
Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited have made an open offer to acquire up to 91,69,632 equity shares of Pharmaids Pharmaceuticals at ₹62.15 per share, totaling ₹56,98,92,629.00. The offer complies with SEBI regulations on substantial acquisition of shares and takeovers. A reminder advertisement was published on August 7, 2025, in various newspapers. Saffron Capital Advisors Private Limited is managing the offer, with contact information provided for clarifications.
25Jul 25
Shankarappa Nagaraja Vinaya Babu Launches Open Offer for 26% Stake in Pharmaids Pharmaceuticals at ₹62.15 Per Share
Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited have announced an open offer to acquire up to 26% stake in Pharmaids Pharmaceuticals at ₹62.15 per share, valuing the deal at ₹56.99 crore. The offer period is from August 4 to August 18, 2025. The acquirers currently hold a combined 24.36% stake, which could increase to 51.28% post-offer. Most existing promoters will seek reclassification as public shareholders, while the acquirers will become new promoters. Pharmaids Pharmaceuticals, engaged in pharmaceutical and biotechnology services, reported a revenue of ₹1,944.74 lakh and a net loss of ₹1,350.51 lakh for FY ending March 31, 2025.
Pharmaids Pharmaceuticals
51.90
+1.95
(+3.90%)
1 Year Returns:-18.77%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)